Rapid Easy Strength Training (REST) to Improve Function in Late Stage Cancer

This study has been completed.
Sponsor:
Information provided by:
Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01334983
First received: April 12, 2011
Last updated: May 25, 2012
Last verified: May 2012
  Purpose

The purpose of this study is to determine whether a gentle physical conditioning program comprised of isotonic resistive strengthening and pedometer-directed walking can improve the physical functioning and fatigue of patients with late stage lung or colon cancer.


Condition Intervention Phase
Cancer
Behavioral: REST
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Phase II Randomized Controlled Trial of Rapid and Easy Strength Training to Preserve Function in Late Stage Cancer

Resource links provided by NLM:


Further study details as provided by Mayo Clinic:

Primary Outcome Measures:
  • Ambulatory Post Acute Care Basic Mobility Short Form [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Patient reported outcome with 18 items assessed functionality in basic mobility. Response option for all items is a 4 level Likert scale


Secondary Outcome Measures:
  • Ambulatory Post Acute Care Short Form Daily Activities [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Patient reported outcome with 15 items assessing functionality with respect to the performance of activities of daily living.

  • Linear Analoge Self Assessment of Quality of Life [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    7 item patient reported outcome assessing over-all quality of life and quality of life domains, e.g. mental, social, etc.

  • FACIT-F [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]
    Patient reported outcome assessing overall quality of life among patients with cancer and fatigue


Enrollment: 68
Study Start Date: June 2010
Study Completion Date: November 2010
Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: REST
Participants instructed in individualized Rapid Easy Strength Training and pedometer-based walking programs
Behavioral: REST
Instruction in an individualized rapid easy strength training (isotonic with therabands) and pedometer-based walking programs.
No Intervention: Wait list control
Participants instructed in REST after completing week 8 outcome measures

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of Stage III or IV NSCLC or extensive stage SCLC, or Stage IV colon cancer
  • fluency in the English language
  • Intact cognitive status (Folstein mini-mental score > 25).

Exclusion Criteria:

  • Pain numeric rating scale (NRS) scores > 7/10,
  • Fatigue NRS score > 8/10,
  • paralysis of > 2 limbs (< antigravity strength in all major muscle groups),
  • Severe cerebellar ataxia,
  • Chronic (> 1 year) non-cancer pain either >5/10 or causing the patient to apply for or receive disability payments.
  • Severe medical or psychiatric co-morbidities such as major depression or unstable angina
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01334983

Locations
United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
  More Information

No publications provided

Responsible Party: Andrea L. Cheville, Mayo Clinic, Rochester MN
ClinicalTrials.gov Identifier: NCT01334983     History of Changes
Other Study ID Numbers: 09-007108
Study First Received: April 12, 2011
Last Updated: May 25, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by Mayo Clinic:
cancer
function
fatigue
late stage
metastases
quality of life
functional decline in cancer

ClinicalTrials.gov processed this record on May 23, 2013